Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending February 15, 2011. The report details a specific share repurchase transaction executed under authority granted by shareholders at the Annual General Meeting on May 6, 2010.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on capital structure and share repurchase activity.
- Shares Purchased: 850,000 Ordinary shares of 25 pence each.
- Purchase Date: February 15, 2011.
- Price Range: Highest price paid was 1,185.0 pence per share; lowest price paid was 1,171.5 pence per share.
- Treasury Holdings (Settled): 480,137,284 shares (8.47% of total issued share capital).
- Treasury Holdings (Including Unsettled): 481,887,284 shares (9.28% of total voting rights).
- Shares in Issue (Excluding Treasury): 5,190,646,885 shares.
Material Changes
The filing reports an increase in the Company's treasury share holdings following the purchase of 850,000 shares. Consequently, the percentage of total voting rights held in Treasury increased to 9.28% when including unsettled shares. No other material changes to operations or financial position are disclosed in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The primary purpose is to disclose the share buyback activity and update the share count for regulatory transparency under the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares in issue (5,190,646,885) for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the current percentage of voting rights held in Treasury (9.28% including unsettled shares).
- Review the remaining authority for share repurchases under the mandate granted on May 6, 2010.
- Note that this filing does not contain financial performance data; refer to Form 20-F or quarterly reports for revenue and earnings.